CellCarta and Leica Biosystems expand push to streamline precision medicine development
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
Report reveals growing confidence in AI-driven decision-making, but highlights persistent challenges in scaling digital investments and converting innovation into measurable business value
Subscribe To Our Newsletter & Stay Updated